|
Category:
|
7TM Receptors Peptides (Cardiovascular) Endothelin Receptors ET-A Receptor Compounds
|
|
Cat.No.
|
Product Name
|
|
1210 |
FR 139317
|
|
|
|
Price and Availability
Click here for full price details of
FR 139317
|
|
Chemical Name:
N-[N-[N-[(Hexahydro-1H-azepin-1-yl)carbonyl]-L-leucyl]-
1-methyl-D-tryptophyl]-3-(2-pyridinyl)-D-alanine |
|
|
Biological Activity:
A highly potent and selective ETA
endothelin receptor antagonist (Ki values are 1 nM and 7.3 μM
at ETA and ETB subtypes respectively). Active in vivo.
|
Technical Data:
|
|
|
Resources:
|
|
Certificate of Analysis / MSDS:
|
References:
Sogabe et al (1993) Pharmacological profile of FR139317, a novel, potent
endothelin ETA receptor antagonist. J.Pharmacol.Exp.Ther. 264
1040. Aramori et al (1993) Subtype selectivity of a novel
endothelin antagonist, FR139317, for the two endothelin receptors in
transfected Chinese hamster ovary cells. Mol.Pharmacol. 43 127. Rubanyi
and Polokoff (1994) Endothelins: molecular biology, biochemistry,
pharmacology, physiology, and pathophysiology. Pharmacol.Rev. 46
325. Palacios et al (2002) Role of endothelin ETA- and ETB-receptors in
haemodynamic compensation following haemorrhage in anaesthetized rats.
Br.J.Pharmacol. 135 876.
|
|
View related products by Pharmacological Action
or by Research Area
Keywords: FR 139317, Peptides (Cardiovascular), Highly Potent, Selective ETA Antagonist, FR139317, Tocris Bioscience
|
|
|